Dexcom G7 lowers A1C in trial of Type 2 diabetes patients not using insulin
Dexcom's CONNECT randomized trial results were published in The New England Journal of Medicine, supporting earlier continuous glucose monitoring in Type 2 diabetes. G7 significantly improved glucose control versus routine care in adults not using insulin, with benefits extending to participants taking GLP-1 therapies.